Article Information
History
- January 1, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Farrell A. Tobolowsky, DO, MS1,*,†,
- Michelle A. Waltenburg, DVM, MPH1,*,
- Erin D. Moritz, PhD1,
- Melia Haile, MPH, CHES1,
- Juliana C. DaSilva, MA1,
- Amy J. Schuh, PhD, MPH1,
- Natalie J. Thornburg, PhD1,
- Adrianna Westbrook, MPH1,
- Susannah L. McKay, PhD1,
- Stephen P. LaVoie, PhD1,
- Jennifer M. Folster, PhD1,
- Jennifer L. Harcourt, PhD1,
- Azaibi Tamin1,
- Megan M. Stumpf1,
- Lisa Mills1,
- Brandi Freeman, PhD, MPH1,
- Sandra Lester, PhD1,
- Elizabeth Beshearse, PhD1,
- Kristin D. Lecy, RN, MPH1,
- Laura G. Brown, PhD1,
- Geroncio Fajardo1,
- Jeanne Negley, MBA2,
- L. Clifford McDonald, MD1,
- Preeta K. Kutty, MD, MPH1,
- Allison C. Brown, PhD1,
- for the CDC Infection Prevention and Control Team
- 1Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA, 30333
- 2Georgia Department of Public Health, 2 Peachtree Street, Atlanta, GA, 30303
- ↵†Corresponding Author:
Farrell A. Tobolowsky, DO, MS, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, USA 30329, Phone: 404-718-3635, Email: oqk3{at}cdc.gov
↵* Both authors contributed equally to this work.
Posted January 01, 2022.
Longitudinal serologic and viral testing post–SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort—Georgia, October 2020‒April 2021
